Healthcare
Disc Medicine, Inc.
IRON$78.65-1.72%
Price is delayed.
Add to Watchlist
About Disc Medicine, Inc.
Disc Medicine is a biotech company developing drugs for blood disorders. The company focuses on diseases where the body cannot make enough red blood cells or make them incorrectly, such as certain types of anemia and porphyrias. Their drugs work by targeting the biological processes that control red blood cell production and iron levels in the body. The company was founded in 2017 and is based in Massachusetts.
Loading chart...
Members only
Full research is for ConvictionStocks members
Members read the rest of this page. Where we have it for this company, that is:
- What each number means, in plain English, with the Wall Street name where the two differ.
- A plain-English summary of the company.
- How many analysts cover it, and the count behind each rating.
- Recent news, dated.
Get the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Look up another company
Related Research
More Healthcare stocks to explore